Vident Advisory’s MetLife MET Stock Holding History

Vident Advisory’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.83M	Buy	25,938 +5,901	+29%	+$442K	0.02%	649
2025 Q4	$1.58M	Sell	20,037 -591	-3%	-$46.8K	0.01%	648
2025 Q3	$1.7M	Buy	20,628 +1,363	+7%	+$107K	0.02%	627
2025 Q2	$1.55M	Buy	19,265 +1,415	+8%	+$109K	0.02%	594
2025 Q1	$1.43M	Buy	17,850 +4,290	+32%	+$357K	0.02%	591
2024 Q4	$1.11M	Buy	13,560 +1,485	+12%	+$124K	0.02%	605
2024 Q3	$996K	Buy	12,075 +2,036	+20%	+$152K	0.03%	632
2024 Q2	$705K	Buy	10,039 +1,628	+19%	+$116K	0.02%	725
2024 Q1	$623K	Buy	8,411 +53	+0.6%	+$3.69K	0.01%	732
2023 Q4	$553K	Buy	8,358 +866	+12%	+$54.2K	0.01%	747
2023 Q3	$471K	Buy	+7,492	New	+$467K	0.01%	723

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vident Advisory's MET Position: Q1 2026 in Review

Vident Advisory increased its MetLife (MET) stake by 29% in Q1 2026, buying an estimated $442K and bringing the position to 25,938 shares worth $1.83M. The position accounts for 0.02% of the portfolio, ranked #649.

Vident Advisory first reported a position in MET in Q3 2023 and has held it in 11 quarters since. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Vident Advisory held 25,938 shares of MetLife worth $1.83M as of Q1 2026.
Vident Advisory bought 5,901 MetLife shares in Q1 2026, an estimated $442K.
MetLife made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #649 holding.
Vident Advisory first reported a position in MetLife in Q3 2023 and has held it in 11 quarters since.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.